Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient was cured; 3 culture converted, with 2 continuing and 1 changing therapy; and 1 died from respiratory insufficiency. For 2 patients, QT-interval prolongation but no arrhythmias occurred. Use of this t...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases Vol. 23; no. 10; pp. 1718 - 1721
Main Authors: Maryandyshev, Andrey, Pontali, Emanuele, Tiberi, Simon, Akkerman, Onno, Ganatra, Shashank, Sadutshang, Tsetan Dorji, Alffenaar, Jan-Willem, Amale, Rohit, Mullerpattan, Jai, Topgyal, Sonam, Udwadia, Zarir Farokh, Centis, Rosella, D’Ambrosio, Lia, Sotgiu, Giovanni, Migliori, Giovanni Battista
Format: Journal Article
Language:English
Published: United States U.S. National Center for Infectious Diseases 01.10.2017
Centers for Disease Control and Prevention
Subjects:
ISSN:1080-6040, 1080-6059, 1080-6059
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient was cured; 3 culture converted, with 2 continuing and 1 changing therapy; and 1 died from respiratory insufficiency. For 2 patients, QT-interval prolongation but no arrhythmias occurred. Use of this therapy is justified for patients with limited options.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
1080-6059
DOI:10.3201/eid2310.170834